State of Wisconsin Investment Board Portfolio holdings
AUM
$40.9B
1-Year Return
24.31%
This Quarter Return
+4.87%
1 Year Return
+24.31%
3 Year Return
+99.94%
5 Year Return
+177.86%
10 Year Return
+427.44%
AUM
$35.9B
AUM Growth
+$692M
(+2%)
Cap. Flow
-$609M
Cap. Flow
% of AUM
-1.7%
Top 10 Holdings %
Top 10 Hldgs %
16.09%
Holding
1,660
New
123
Increased
661
Reduced
730
Closed
128
Top Buys
| 1 |
iShares Russell 2000 ETF
IWM
|
+$183M |
| 2 |
HCA Healthcare
HCA
|
+$115M |
| 3 |
AGN
Allergan plc
AGN
|
+$108M |
| 4 |
Willis Towers Watson
WTW
|
+$103M |
| 5 |
Parker-Hannifin
PH
|
+$99.2M |
Top Sells
| 1 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$168M |
| 2 |
Apple
AAPL
|
+$89.4M |
| 3 |
Microsoft
MSFT
|
+$86.5M |
| 4 |
Johnson & Johnson
JNJ
|
+$79.1M |
| 5 |
JPMorgan Chase
JPM
|
+$68M |
Sector Composition
| 1 | Technology | 17.85% |
| 2 | Financials | 16.67% |
| 3 | Healthcare | 13.41% |
| 4 | Consumer Discretionary | 10.38% |
| 5 | Industrials | 10.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
DNKN
1176
DELISTED
Dunkin' Brands Group, Inc.
DNKN
| $879K | ﹤0.01% |
11,034
-4,420
| -29% | -$352K |
|
|
GLIBA
1177
DELISTED
GCI Liberty, Inc. Class A Common Stock (DE)
GLIBA
| $861K | ﹤0.01% |
14,010
-4,782
| -25% | -$294K |
|
1178
Allogene Therapeutics
ALLO
$251M
| $859K | ﹤0.01% |
+32,000
| New | +$859K |
|
1179
Assembly Biosciences
ASMB
$168M
| $859K | ﹤0.01% |
5,307
+1,157
| +28% | +$187K |
|
|
STML
1180
DELISTED
Stemline Therapeutics, Inc.
STML
| $852K | ﹤0.01% |
55,600
+17,700
| +47% | +$271K |
|
1181
Commerce Bancshares
CBSH
$7.96B
| $847K | ﹤0.01% |
19,027
-5,923
| -24% | -$264K |
|
1182
Aecom
ACM
$16.8B
| $843K | ﹤0.01% |
22,269
-6,746
| -23% | -$255K |
|
1183
Wolfspeed
WOLF
$365M
| $843K | ﹤0.01% |
+15,009
| New | +$843K |
|
1184
Precigen
PGEN
$1.13B
| $842K | ﹤0.01% |
109,900
+2,400
| +2% | +$18.4K |
|
|
ITCI
1185
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $842K | ﹤0.01% |
64,900
+5,000
| +8% | +$64.9K |
|
1186
First American
FAF
$6.87B
| $833K | ﹤0.01% |
15,510
-4,712
| -23% | -$253K |
|
|
RARX
1187
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
| $824K | ﹤0.01% |
27,400
+7,900
| +41% | +$238K |
|
1188
ITT
ITT
$13.8B
| $817K | ﹤0.01% |
12,473
-3,838
| -24% | -$251K |
|
1189
Anika Therapeutics
ANIK
$125M
| $816K | ﹤0.01% |
+20,100
| New | +$816K |
|
1190
Voyager Therapeutics
VYGR
$232M
| $811K | ﹤0.01% |
29,800
+700
| +2% | +$19.1K |
|
1191
Kura Oncology
KURA
$711M
| $807K | ﹤0.01% |
41,000
+900
| +2% | +$17.7K |
|
|
EGRX
1192
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $802K | ﹤0.01% |
14,400
+300
| +2% | +$16.7K |
|
1193
Chemed
CHE
$6.5B
| $801K | ﹤0.01% |
2,220
-675
| -23% | -$244K |
|
1194
Healthcare Realty
HR
$6.45B
| $797K | ﹤0.01% |
29,073
-9,397
| -24% | -$258K |
|
|
GWR
1195
DELISTED
Genesee & Wyoming Inc.
GWR
| $797K | ﹤0.01% |
7,971
-2,886
| -27% | -$289K |
|
|
GRA
1196
DELISTED
W.R. Grace & Co.
GRA
| $796K | ﹤0.01% |
10,464
-4,226
| -29% | -$321K |
|
1197
Park Hotels & Resorts
PK
$2.39B
| $792K | ﹤0.01% |
28,751
-8,965
| -24% | -$247K |
|
1198
Grand Canyon Education
LOPE
$5.89B
| $789K | ﹤0.01% |
6,743
-2,059
| -23% | -$241K |
|
1199
Intellia Therapeutics
NTLA
$1.23B
| $789K | ﹤0.01% |
48,200
-200
| -0.4% | -$3.27K |
|
1200
Quanta Services
PWR
$57B
| $782K | ﹤0.01% |
20,485
-7,025
| -26% | -$268K |
|